Literature DB >> 8198558

Inactivation of yeast hexokinase by Cibacron Blue 3G-A: spectral, kinetic and structural investigations.

R N Puri1, R Roskoski.   

Abstract

Yeast hexokinase, a homodimer (100 kDa), is an important enzyme in the glycolytic pathway. Although Cibacron Blue 3G-A (Reactive Blue 2) has been previously shown to inactivate yeast hexokinase, no comprehensive study exists concerning the nature of interaction(s) between hexokinase and the blue dye. A comparison of the computer-generated three-dimensional (3D) representations showed considerable overlap of the purine ring of ATP, a nucleotide substrate of hexokinase, with the hydrophobic anthraquinone moiety of the blue dye. The visible spectrum of the blue dye showed a characteristic absorption band centred at 628 nm. The visible difference spectrum of increasing concentration of the dye and the same concentrations of the dye plus a fixed concentration of hexokinase exhibited a maximum, a minimum and an isobestic point at 683, 585, and 655 nm respectively. The visible difference spectrum of the blue dye and the dye in 50% ethylene glycol showed a maximum and a minimum at 660 and 570 nm respectively. The visible difference spectrum of the blue dye in the presence of the dye and hexokinase modified at the active site by pyridoxal phosphate, iodoacetamide and o-phthalaldehyde was devoid of bands characteristic of the hexokinase-blue dye complex. Size-exclusion-chromatographic studies in the absence or presence of guanidinium chloride showed that the enzyme inactivated by the blue dye was co-eluted with the unmodified enzyme. The dialysis residue obtained after extensive dialysis of the gel-filtered complex, against a buffer of high ionic strength, showed an absorption maximum at 655 nm characteristic of the dye-enzyme complex. Inactivation data when analysed by 'Kitz-Wilson'-type kinetics for an irreversible inhibitor, yielded values of 0.05 min-1 and 92 microM for maximum rate of inactivation (k3) and dissociation constant (Kd) for the enzyme-dye complex respectively. Sugar and nucleotide substrates protected hexokinase against inactivation by the blue dye. About 2 mol of the blue dye bound per mol of hexokinase after complete inactivation. The inactivated enzyme could not be re-activated in the presence of 1 M NaCl. These results suggest that Cibacron Blue 3G-A inactivated hexokinase by an irreversible adduct formation at or near the active-site. Spectral and kinetic studies coupled with an analysis of the 3D representations of model compounds corresponding to the substructures of the blue dye suggest that 1-amino-4-(N-phenylamino)anthraquinone-2-sulphonic acid part of the blue dye may represent the minimum structure of Cibacron Blue 3G-A necessary to bind hexokinase.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198558      PMCID: PMC1138128          DOI: 10.1042/bj3000091

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Blue dextran-sepharose: an affinity column for the dinucleotide fold in proteins.

Authors:  S T Thompson; K H Cass; E Stellwagen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Affinity chromatography of kinases and dehydrogenases on Sephadex and Sepharose dye derivatives.

Authors:  R L Easterday; I M Easterday
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

3.  Dissociation of yeast hexokinase under the influence of substrates.

Authors:  M Derechin; Y M Rustum; E A Barnard
Journal:  Biochemistry       Date:  1972-05-09       Impact factor: 3.162

4.  Rapid purification of lactate dehydrogenase from rat liver and hepatoma: a new approach.

Authors:  L D Ryan; C S Vestling
Journal:  Arch Biochem Biophys       Date:  1974-01       Impact factor: 4.013

5.  Binding of salicylate in the adenosine-binding pocket of dehydrogenases.

Authors:  R Einarsson; H Eklund; E Zeppezauer; T Boiwe; C I Brändén
Journal:  Eur J Biochem       Date:  1974-11-01

6.  Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A.

Authors:  H J Böhme; G Kopperschläger; J Schulz; E Hofmann
Journal:  J Chromatogr       Date:  1972-06-28

7.  On the prevalence of "nonspecific" binding at the specific binding sites of globular proteins.

Authors:  A N Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-04       Impact factor: 11.205

8.  Essential thiols of yeast hexokinase: alkylation by a substrate-like reagent.

Authors:  S Otieno; A K Bhargava; E A Barnard; A H Ramel
Journal:  Biochemistry       Date:  1975-06-03       Impact factor: 3.162

9.  Selective removal of albumin from plasma by affinity chromatography.

Authors:  J Travis; R Pannell
Journal:  Clin Chim Acta       Date:  1973-11-23       Impact factor: 3.786

10.  Adenosine cyclic 3',5'-monophosphate dependent protein kinase: active site directed inhibition by Cibacron Blue F3GA.

Authors:  J J Witt; R Roskoski
Journal:  Biochemistry       Date:  1980-01-08       Impact factor: 3.162

View more
  4 in total

1.  The glycolytic function of hexokinases is not required for catabolite repression in Candida utilis.

Authors:  A E Espinel; J S Leyva; V Gómez-Toribio; J M Peinado
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

2.  Purification and characterization of sn-1-stearoyl-2-arachidonoylglycerol kinase from pig testes.

Authors:  M N Hodgkin; S D Gardner; S Rose; A Paterson; A Martin; M J Wakelam
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

3.  Characterization and heterologous expression of hydroxycinnamoyl/benzoyl-CoA:anthranilate N-hydroxycinnamoyl/benzoyltransferase from elicited cell cultures of carnation, Dianthus caryophyllus L.

Authors:  Q Yang; K Reinhard; E Schiltz; U Matern
Journal:  Plant Mol Biol       Date:  1997-12       Impact factor: 4.076

Review 4.  The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics.

Authors:  Nazly Shafagati; Alexis Patanarut; Alessandra Luchini; Lindsay Lundberg; Charles Bailey; Emanuel Petricoin; Lance Liotta; Aarthi Narayanan; Benjamin Lepene; Kylene Kehn-Hall
Journal:  Pathog Dis       Date:  2014-03-20       Impact factor: 3.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.